Page 3 - Johnson Stelara News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs

Fast-approaching patent expirations will take a bite out of revenues and put the industry’s top players in the hot seat over the next few years.

United statesAbbvie humiraBristol myers squibb opdivoJohnson stelaraMike perronePiper sandlerChristopher raymondDaiichi sankyoJpmorgan schottMerck keytrudaBristol myers squibb eliquisMatt phippsRobert davisChris schottWilliam blair companyBristol myers squibb

STADA and Alvotech s win first EU-approval for Stelara biosimilar - Pharmaceutical Technology

STADA and Alvotech’s Uzpruvo gained an EU marketing authorisation, allowing it to be sold in the European Economic Area in 2024.

Johnson stelaraBryan kimEuropean commission for uzpruvoCommittee for medicinal products human useCompany profilesCompany profileEuropean commissionDrug administrationEuropean economic areaMedicinal productsHuman useSupplementary protection certificateBiologics licensingSpecialty head

JPM24: Amgen CEO hopes to take a bite of competitive obesity market with unique approach

JPM24: Amgen CEO hopes to take a bite of competitive obesity market with unique approach
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesRegeneron eyleaRobert bradwayAstrazeneca solirisEli lillyJohnson stelaraNovo nordiskBristol myers squibbHealthcare conference

Johnson & Johnson s Bullish Outlook: Surprising Strength You Shouldn t Overlook (NYSE:JNJ)

Johnson & Johnson s Bullish Outlook: Surprising Strength You Shouldn t Overlook (NYSE:JNJ)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesJohnson stelaraAbbvie humiraBeigene brukinsaJames conlanEli lilly jaypircaInflation reduction actPayout ratioSimponi ariaTeva pharmaceuticalNovarti cosentyxSeeking alphaInnovative medicineWall streetBristol myers squibbInflation reduction

Investor s Dilemma: AbbVie Stock Amidst US Election And Humira Decline (NYSE:ABBV)

Investor s Dilemma: AbbVie Stock Amidst US Election And Humira Decline (NYSE:ABBV)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesBeigene brukinsaJohnson stelaraIncyte opzeluraAmgen amgevitaAstrazeneca calquenceFresenius kabiEli lilly jaypircaAmgen otezlaGilead sciencesBoehringer ingelheimBiden harris administrationFederal reserveInside creativePresident bidenInflation reduction act